FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Dorte Gyrd-Hansen

Research Profile

Geographic Areas

Denmark

Activities & Behaviors

Concepts & Ideas

Co-author Network

Publications

TOP 3
Kim Rose Olsen; Torben Højmark Sørensen; Dorte Gyrd-Hansen; Troels Kristensen; Peter Vedsted; Andrew Street
Organisational determinants of production and efficiency in general practice: a population-based study.
Rikke Søgaard; Jes Lindholt; Dorte Gyrd-Hansen
Individual decision making in relation to participation in cardiovascular screening: a study of revealed and stated preferences.
Charlotte Gry Harmsen; Dorte Ejg Jarbøl; Adrian Edwards; Dorte Gyrd-Hansen; Jørgen Nexøe; Jesper Bo Nielsen; Henrik Støvring; Ivar Sønbø Kristiansen
Impact of effectiveness information format on patient choice of therapy and satisfaction with decisions about chronic disease medication: the "Influence of intervention Methodologies on Patient Choice of Therapy (IMPACT)" cluster-randomised trial in general practice.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Dorte Gyrd-Hansen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Kim Rose Olsen; Torben Højmark Sørensen; Dorte Gyrd-Hansen; Troels Kristensen; Peter Vedsted; Andrew Street
Organisational determinants of production and efficiency in general practice: a population-based study.
The European journal of health economics : HEPAC : health economics in prevention and care 2013;14(2):267-76.
2013: Rikke Søgaard; Jes Lindholt; Dorte Gyrd-Hansen
Individual decision making in relation to participation in cardiovascular screening: a study of revealed and stated preferences.
Scandinavian journal of public health 2013;41(1):43-50.
2013: Charlotte Gry Harmsen; Dorte Ejg Jarbøl; Adrian Edwards; Dorte Gyrd-Hansen; Jørgen Nexøe; Jesper Bo Nielsen; Henrik Støvring; Ivar Sønbø Kristiansen
Impact of effectiveness information format on patient choice of therapy and satisfaction with decisions about chronic disease medication: the "Influence of intervention Methodologies on Patient Choice of Therapy (IMPACT)" cluster-randomised trial in general practice.
BMC health services research 2013;13():76.
2012: Rikke Søgaard; Jes Lindholt; Dorte Gyrd-Hansen
Insensitivity to scope in contingent valuation studies: reason for dismissal of valuations?
Applied health economics and health policy 2012;10(6):397-405.
2012: Natalie M Spearing; Dorte Gyrd-Hansen; Louis H Pobereskin; David S Rowell; Luke B Connelly
Are people who claim compensation "cured by a verdict"? A longitudinal study of health outcomes after whiplash.
Journal of law and medicine 2012;20(1):82-92.
2012: Jytte Seested Nielsen; Dorte Gyrd-Hansen; Trine Kjaer
Valuation of morbidity and mortality risk reductions. Does context matter?
Accident; analysis and prevention 2012;48():246-53.
2012: Line Bjørnskov Pedersen; Trine Kjaer; Jakob Kragstrup; Dorte Gyrd-Hansen
General practitioners' preferences for the organisation of primary care: a discrete choice experiment.
Health policy (Amsterdam, Netherlands) 2012;106(3):246-56.
2012: Line Bjørnskov Pedersen; Trine Kjaer; Jakob Kragstrup; Dorte Gyrd-Hansen
Do general practitioners know patients' preferences? An empirical study on the agency relationship at an aggregate level using a discrete choice experiment.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2012;15(3):514-23.
2012: Dorte Gyrd-Hansen; Trine Kjaer
Disentangling WTP per QALY data: different analytical approaches, different answers.
Health economics 2012;21(3):222-37.
2012: Dorte Gyrd-Hansen; Kim Rose Olsen
[Cost of vaccination and cost of sick leave are determinants of cost-effectiveness vaccination against rotavirus].
Ugeskrift for laeger 2012;174(8):480-3.
2012: Charlotte Gry Harmsen; Dorte Ejg Jarbøl; Adrian Edwards; Dorte Gyrd-Hansen; Jørgen Nexøe; Jesper Bo Nielsen; Henrik Støvring; Ivar Sønbø Kristiansen
Medication effectiveness may not be the major reason for accepting cardiovascular preventive medication: a population-based survey.
BMC medical informatics and decision making 2012;12():89.
2011: Lene Halling Hastrup; Merete Nordentoft; Carsten Hjorthøj; Dorte Gyrd-Hansen
Does the EQ-5D measure quality of life in schizophrenia?
The journal of mental health policy and economics 2011;14(4):187-96.
2011: Betina Højgaard; Kim Rose Olsen; Charlotta Pisinger; Hanne Tønnesen; Dorte Gyrd-Hansen
The potential of smoking cessation programmes and a smoking ban in public places: comparing gain in life expectancy and cost effectiveness.
Scandinavian journal of public health 2011;39(8):785-96.
2011: Anne Hvenegaard; Andrew Street; Jacob Nielsen Arendt; Dorte Gyrd-Hansen
Exploring the relationship between costs and quality: does the joint evaluation of costs and quality alter the ranking of Danish hospital departments?
The European journal of health economics : HEPAC : health economics in prevention and care 2011;12(6):541-51.
2011: Line Bjørnskov Pedersen; Dorte Gyrd-Hansen; Trine Kjaer
The influence of information and private versus public provision on preferences for screening for prostate cancer: a willingness-to-pay study.
Health policy (Amsterdam, Netherlands) 2011;101(3):277-89.
2011: Karin Dam Petersen; Christian Kronborg; Dorte Gyrd-Hansen; Ronald Dahl; Jørgen Nedergaard Larsen; Allan Linneberg
Characteristics of patients receiving allergy vaccination: to which extent do socio-economic factors play a role?
European journal of public health 2011;21(3):323-8.
2011: Louise Herbild; Mickael Bech; Dorte Gyrd-Hansen; Mona Christensen; Thomas Werge; Kirsten Annette Nielsen
Do guidelines recommending pharmacogenetic testing of psychiatric patients affect treatment costs and the use of healthcare services?
Scandinavian journal of public health 2011;39(2):147-55.
2011: Dorte Gyrd-Hansen; Peder Andreas Halvorsen; Jørgen Nexøe; Jesper Nielsen; Henrik Støvring; Ivar Sønbø Kristiansen
Joint and separate evaluation of risk reduction: impact on sensitivity to risk reduction magnitude in the context of 4 different risk information formats.
Medical decision making : an international journal of the Society for Medical Decision Making 2011;31(1):E1-10.
2010: Dorthe Fuglenes; Pål Oian; Dorte Gyrd-Hansen; Jan Abel Olsen; Ivar S Kristiansen
Norwegian obstetricians' opinions about cesarean section on maternal request: should women pay themselves?
Acta obstetricia et gynecologica Scandinavica 2010;89(12):1582-8.
2010: Jesper Bo Nielsen; Arthur Elstein; Dorte Gyrd-Hansen; Helle Wallach Kildemoes; Ivar Sønbø Kristiansen; Henrik Støvring
Effects of alternative styles of risk information on EMF risk perception.
Bioelectromagnetics 2010;31(7):504-12.
2010: Maria Knoph Kvamme; Dorte Gyrd-Hansen; Jan Abel Olsen; Ivar Sønbø Kristiansen
Increasing marginal utility of small increases in life-expectancy? Results from a population survey.
Journal of health economics 2010;29(4):541-8.
2010: Arna S Desser; Dorte Gyrd-Hansen; Jan Abel Olsen; Sverre Grepperud; Ivar Sønbø Kristiansen
Societal views on orphan drugs: cross sectional survey of Norwegians aged 40 to 67.
BMJ (Clinical research ed.) 2010;341():c4715.
2010: Karin Dam Petersen; Dorte Gyrd-Hansen; Allan Linneberg; Ronald Dahl; Jørgen Nedergaard Larsen; Henning Løwenstein; Christian Kronborg
Willingness to pay for allergy-vaccination among Danish patients with respiratory allergy.
International journal of technology assessment in health care 2010;26(1):20-9.
2009: Betina Højgaard; Kim Rose Olsen; Jes Søgaard; Dorte Gyrd-Hansen; Thorkild I A Sørensen
[Obesity related health care costs assessed from BMI or waist circumference--secondary publication].
Ugeskrift for laeger 2009;171(43):3068-71.
2009: Torben H Sørensen; Kim R Olsen; Dorte Gyrd-Hansen
Differences in general practice initiated expenditures across Danish local health authorities-A multilevel analysis.
Health policy (Amsterdam, Netherlands) 2009;92(1):35-42.
2009: Anne Hvenegaard; Andrew Street; Torben Højmark Sørensen; Dorte Gyrd-Hansen
Comparing hospital costs: what is gained by accounting for more than a case-mix index?
Social science & medicine (1982) 2009;69(4):640-7.
2009: Ivar S Kristiansen; Arthur S Elstein; Dorte Gyrd-Hansen; Helle W Kildemoes; Jesper B Nielsen
Radiation from mobile phone systems: Is it perceived as a threat to people's health?
Bioelectromagnetics 2009;30(5):393-401.
2009: Marie Kruse; Jan Sørensen; Michael Davidsen; Dorte Gyrd-Hansen
Short and long-term labour market consequences of coronary heart disease: a register-based follow-up study.
European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 2009;16(3):387-91.
2009: Louise Herbild; Mickael Bech; Dorte Gyrd-Hansen
Estimating the Danish populations' preferences for pharmacogenetic testing using a discrete choice experiment. The case of treating depression.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2009;12(4):560-7.
2008: Marie Kruse; Michael Davidsen; Mette Madsen; Dorte Gyrd-Hansen; Jan Sørensen
Costs of heart disease and risk behaviour: implications for expenditure on prevention.
Scandinavian journal of public health 2008;36(8):850-6.
2008: Dorte Gyrd-Hansen; Ivar Sønbø Kristiansen
Preferences for 'life-saving' programmes: small for all or gambling for the prize?
Health economics 2008;17(6):709-20.
2008: K D Petersen; C Kronborg; Dorte Gyrd-Hansen; R Dahl; Jørgen Nedergaard Larsen; Henning Løwenstein
Quality of life in rhinoconjunctivitis assessed with generic and disease-specific questionnaires.
Allergy 2008;63(3):284-91.
2008: Betina Højgaard; Kim Rose Olsen; Jes Søgaard; Thorkild I A Sørensen; Dorte Gyrd-Hansen
Economic costs of abdominal obesity.
Obesity facts 2008;1(3):146-54.
2008: Lene Sorensen; Dorte Gyrd-Hansen; Ivar Sønbø Kristiansen; Jørgen Nexøe; Jesper Bo Nielsen
Laypersons' understanding of relative risk reductions: randomised cross-sectional study.
BMC medical informatics and decision making 2008;8():31.
2008: Betina Højgaard; Dorte Gyrd-Hansen; Kim Rose Olsen; Jes Søgaard; Thorkild I A Sørensen
Waist circumference and body mass index as predictors of health care costs.
PloS one 2008;3(7):e2619.
2008: Henrik Stovring; Dorte Gyrd-Hansen; Ivar Sønbø Kristiansen; Jorgen Nexoe; Jesper B Nielsen
Communicating effectiveness of intervention for chronic diseases: what single format can replace comprehensive information?
BMC medical informatics and decision making 2008;8():25.
2008: Louise Herbild; Dorte Gyrd-Hansen; Mickael Bech
Patient preferences for pharmacogenetic screening in depression.
International journal of technology assessment in health care 2008;24(1):96-103.
2008: Trine Kjaer; Dorte Gyrd-Hansen
Preference heterogeneity and choice of cardiac rehabilitation program: results from a discrete choice experiment.
Health policy (Amsterdam, Netherlands) 2008;85(1):124-32.
2008: Dorte Gyrd-Hansen; Peder Andreas Halvorsen; Ivar Sønbø Kristiansen
Willingness-to-pay for a statistical life in the times of a pandemic.
Health economics 2008;17(1):55-66.
2007: Mickael Bech; Dorte Gyrd-Hansen; Trine Kjaer; Jørgen Lauridsen; Jan Sørensen
Graded pairs comparison - does strength of preference matter? Analysis of preferences for specialised nurse home visits for pain management.
Health economics 2007;16(5):513-29.
2007: Ivar Sønbø Kristiansen; Dorte Gyrd-Hansen
[Prioritization and health--should maximum-price life years be introduced?].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2007;127(1):54-7.
2007: Ivar Sønbø Kristiansen; Peder Andreas Halvorsen; Dorte Gyrd-Hansen
Influenza pandemic: perception of risk and individual precautions in a general population. Cross sectional study.
BMC public health 2007;7():48.
2007: Rasmus Dahl; Dorte Gyrd-Hansen; Ivar Sønbø Kristiansen; Jørgen Nexøe; Jesper Bo Nielsen
Can postponement of an adverse outcome be used to present risk reductions to a lay audience? A population survey.
BMC medical informatics and decision making 2007;7():8.
2006: Ivar Sønbø Kristiansen; Dorte Gyrd-Hansen
Communicating treatment effectiveness in the context of chronic disease processes.
Expert review of pharmacoeconomics & outcomes research 2006;6(6):673-9.
2006: Trine Kjaer; Mickael Bech; Dorte Gyrd-Hansen; Kristian Hart-Hansen
Ordering effect and price sensitivity in discrete choice experiments: need we worry?
Health economics 2006;15(11):1217-28.
2006: Ivar Sønbø Kristiansen; Dorte Gyrd-Hansen; Jørgen Nexøe; Jesper Bo Nielsen
Willingness-to-pay for a population program aimed at reducing dietary salt in Denmark.
Preventive medicine 2006;43(1):31-5.
2006: Helle Wallach Kildemoes; Terkel Christiansen; Dorte Gyrd-Hansen; Ivar Sønbø Kristiansen; Morten Andersen
The impact of population ageing on future Danish drug expenditure.
Health policy (Amsterdam, Netherlands) 2006;75(3):298-311.
2006: Mickael Bech; Terkel Christiansen; Dorte Gyrd-Hansen
Handling value added tax (VAT) in economic evaluations: should prices include VAT?
Applied health economics and health policy 2006;5(4):209-13.
2006: Trine Kjaer; Dorte Gyrd-Hansen; Ingrid Willaing
Investigating patients' preferences for cardiac rehabilitation in Denmark.
International journal of technology assessment in health care 2006;22(2):211-8.
2005: K D Petersen; Dorte Gyrd-Hansen; R Dahl
Health-economic analyses of subcutaneous specific immunotherapy for grass pollen and mite allergy.
Allergologia et immunopathologia 2005;33(6):296-302.
2005: Ivar Sønbø Kristiansen; Palle M Christensen; Dorte Gyrd-Hansen
Benign breast disease and breast cancer.
The New England journal of medicine 2005;353(17):1856-8; author reply 1856-8.
2005: Mickael Bech; Dorte Gyrd-Hansen
Effects coding in discrete choice experiments.
Health economics 2005;14(10):1079-83.
2005: K Dam Petersen; Dorte Gyrd-Hansen; S Kjaergaard; R Dahl
Clinical and patient based evaluation of immunotherapy for grass pollen and mite allergy.
Allergologia et immunopathologia 2005;33(5):264-9.
2005: Dorte Gyrd-Hansen
[The future of pharmacogenetics--cost-effectiveness and barriers].
Ugeskrift for laeger 2005;167(20):2153-5.
2005: Palle Mark Christensen; Kim Brixen; Dorte Gyrd-Hansen; Ivar Sønbø Kristiansen
Cost-effectiveness of alendronate in the prevention of osteoporotic fractures in Danish women.
Basic & clinical pharmacology & toxicology 2005;96(5):387-96.
2005: Jørgen Nexøe; Ivar Sønbø Kristiansen; Dorte Gyrd-Hansen; Jesper Bo Nielsen
Influence of number needed to treat, costs and outcome on preferences for a preventive drug.
Family practice 2005;22(1):126-31.
2005: Eva Draborg; Dorte Gyrd-Hansen
Time-trends in health technology assessments: an analysis of developments in composition of international health technology assessments from 1989 to 2002.
International journal of technology assessment in health care 2005;21(4):492-8.
2005: Dorte Gyrd-Hansen
Willingness to pay for a QALY: theoretical and methodological issues.
PharmacoEconomics 2005;23(5):423-32.
2005: Eva Draborg; Dorte Gyrd-Hansen; Peter Bo Poulsen; Mogens Horder
International comparison of the definition and the practical application of health technology assessment.
International journal of technology assessment in health care 2005;21(1):89-95.
2004: Dorte Gyrd-Hansen
Investigating the social value of health changes.
Journal of health economics 2004;23(6):1101-16.
2004: Ivar Sønbø Kristiansen; Dorte Gyrd-Hansen
Cost-effectiveness analysis based on the number-needed-to-treat: common sense or non-sense?
Health economics 2004;13(1):9-19.
2003: Dorte Gyrd-Hansen
Willingness to pay for a QALY.
Health economics 2003;12(12):1049-60.
2003: Dorte Gyrd-Hansen; Ivar Sønbø Kristiansen; Jørgen Nexøe; Jesper Bo Nielsen
How do individuals apply risk information when choosing among health care interventions?
Risk analysis : an official publication of the Society for Risk Analysis 2003;23(4):697-704.
2003: Ulla Slothuus Skjoldborg; Dorte Gyrd-Hansen
Conjoint analysis. The cost variable: an Achilles' heel?
Health economics 2003;12(6):479-91.
2002: Ivar Sønbø Kristiansen; Dorte Gyrd-Hansen; Jørgen Nexøe; Jesper Bo Nielsen
The concept of risk: a comment to Reventlow and co-workers.
Scandinavian journal of primary health care 2002;20(4):252; author reply 253.
2002: Jørgen Nexøe; Dorte Gyrd-Hansen; Jakob Kragstrup; Ivar Sønbø Kristiansen; Jesper Bo Nielsen
[General practitioners' perception of disease risks and benefit of prevention].
Ugeskrift for laeger 2002;164(46):5379-82.
2002: Ivar Sønbø Kristiansen; Jørgen Nexøe; Dorte Gyrd-Hansen; Jesper Bo Nielsen
NNT is not easily understood.
Family practice 2002;19(5):566; author reply 566-7.
2002: Ivar Sønbø Kristiansen; Dorte Gyrd-Hansen; Jørgen Nexøe; Jesper Bo Nielsen
Number needed to treat: easily understood and intuitively meaningful? Theoretical considerations and a randomized trial.
Journal of clinical epidemiology 2002;55(9):888-92.
2002: Randi Nielsen; Dorte Gyrd-Hansen
Prenatal screening for cystic fibrosis: an economic analysis.
Health economics 2002;11(4):285-99.
2002: Dorte Gyrd-Hansen; Ulla Slothuus
The citizen's preferences for financing public health care: a Danish survey.
International journal of health care finance and economics 2002;2(1):25-36.
2002: Jørgen Nexøe; Dorte Gyrd-Hansen; Jakob Kragstrup; Ivar Sønbø Kristiansen; Jesper Bo Nielsen
Danish GPs' perception of disease risk and benefit of prevention.
Family practice 2002;19(1):3-6.
2002: Dorte Gyrd-Hansen
Comparing the results of applying different methods of eliciting time preferences for health.
The European journal of health economics : HEPAC : health economics in prevention and care 2002;3(1):10-6.
2002: Dorte Gyrd-Hansen; Ivar Sønbø Kristiansen; Jørgen Nexøe; Jesper Bo Nielsen
Effects of baseline risk information on social and individual choices.
Medical decision making : an international journal of the Society for Medical Decision Making 2002;22(1):71-5.
2001: Dorte Gyrd-Hansen; J Søgaard
Analysing public preferences for cancer screening programmes.
Health economics 2001;10(7):617-34.
2000: Mickael Bech; Dorte Gyrd-Hansen
Cost implications of routine mammography screening of women 50-69 years in the county of Funen, Denmark.
Health policy (Amsterdam, Netherlands) 2000;54(2):125-41.
2000: Dorte Gyrd-Hansen
Cost-benefit analysis of mammography screening in Denmark based on discrete ranking data.
International journal of technology assessment in health care 2000;16(3):811-21.
1999: Dorte Gyrd-Hansen
The relative economics of screening for colorectal cancer, breast cancer and cervical cancer.
Critical reviews in oncology/hematology 1999;32(2):133-44.
1998: Dorte Gyrd-Hansen; J Søgaard
Discounting life-years: whither time preference?
Health economics 1998;7(2):121-7.
1998: Dorte Gyrd-Hansen; J Søgaard; O Kronborg
Colorectal cancer screening: efficiency and effectiveness.
Health economics 1998;7(1):9-20.
1998: J Søgaard; Dorte Gyrd-Hansen
Counting and discounting gained life-years.
Developments in health economics and public policy 1998;6():51-74.
1997: Dorte Gyrd-Hansen; J Søgaard; O Kronborg
Analysis of screening data: colorectal cancer.
International journal of epidemiology 1997;26(6):1172-81.
1997: Dorte Gyrd-Hansen
Is it cost effective to introduce screening programmes for colorectal cancer? Illustrating the principles of optimal resource allocation.
Health policy (Amsterdam, Netherlands) 1997;41(3):189-99.
1996: Dorte Gyrd-Hansen; B Hølund; P Andersen
[Costs and effects of alternative screening programs against cervical cancer].
Ugeskrift for laeger 1996;158(35):4912-5.
1995: Dorte Gyrd-Hansen; B Hølund; P Andersen
A cost-effectiveness analysis of cervical cancer screening: health policy implications.
Health policy (Amsterdam, Netherlands) 1995;34(1):35-51.